Evidence map›Paper›PMID 30181242›Full record

ArticleScience signaling2018

Targeting nucleotide exchange to inhibit constitutively active G protein α subunits in cancer cells.

Michael D Onken, Carol M Makepeace, Kevin M Kaltenbronn, Stanley M Kanai, Tyson D Todd, Shiqi Wang, Thomas J Broekelmann, Prabakar Kumar Rao, John A Cooper, Kendall J Blumer

Open access · greenAbstract read
In one paragraph

Article in Science signaling, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 106 citations in OpenAlex.

  1. G protein GαThe Journal of biological chemistry · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Allele-specific depletion ofMolecular therapy. Oncology · 2025
    Article
  8. Cyclic peptide inhibitors function as molecular glues to stabilize Gq/11 heterotrimers.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Contract to kill: GNAS mutation.Molecular cancer · 2025
    Review
  14. Article
  15. The G protein inhibitor YM-254890 is an allosteric glue.bioRxiv : the preprint server for biology · 2024
    Article
  16. Review
  17. Review
  18. Stabilization of interdomain closure by a G protein inhibitor.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  19. Article
  20. Article

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Michael D OnkenDepartment of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, MO 63110, USA. mdonken@wustl.edu kblumer@wustl.edu.ORCID 0000-0003-4082-1105
Carol M MakepeaceDepartment of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Kevin M KaltenbronnDepartment of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, MO 63110, USA.ORCID 0000-0001-8331-5718
Stanley M KanaiDepartment of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, MO 63110, USA.ORCID 0000-0001-9074-0624
Tyson D ToddDepartment of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Shiqi WangDepartment of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, MO 63110, USA.
Thomas J BroekelmannDepartment of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, MO 63110, USA.ORCID 0000-0002-5563-6538
Prabakar Kumar RaoDepartment of Ophthalmology, Washington University School of Medicine, St. Louis, MO 63110, USA.ORCID 0000-0002-8445-7897
John A CooperDepartment of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, MO 63110, USA.
Kendall J BlumerDepartment of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, MO 63110, USA. mdonken@wustl.edu kblumer@wustl.edu.ORCID 0000-0002-5743-6206
Washington University in St. Louis · US

Funding

Washington University Center for Cellular ImagingP30CA091842 · NCI · WASHINGTON UNIVERSITY · PI TIMOTHY J. EBERLEIN · 2001 to 2026
$128.0M
MECHANISM &REGULATION OF RECEPTOR G PROTEIN SIGNALINGR01GM044592 · NIGMS · WASHINGTON UNIVERSITY · PI BLUMER, KENDALL J · 1990 to 2017
$7.5M
Pediatric Cardiovascular and Pulmonary Research Training Program.T32HL125241 · NHLBI · WASHINGTON UNIVERSITY · PI Juliane Bubeck Wardenburg, Kory J. Lavine · 2015 to 2026
$4.1M
PHARMACOLOGICAL TARGETING OF GALPHA SUBUNITS IN DISEASER01GM124093 · NIGMS · WASHINGTON UNIVERSITY · PI BLUMER, KENDALL J, MOELLER, KEVIN DAVID · 2017 to 2024
$3.6M
ACTIN ASSEMBLY AND CELL MOTILITY: MECHANISMS AND REGULATIONR35GM118171 · NIGMS · WASHINGTON UNIVERSITY · PI COOPER, JOHN A · 2016 to 2020
$2.8M
NCI NIH HHS P30 CA091842NIGMS NIH HHS R01 GM044592NIGMS NIH HHS R01 GM124093NIGMS NIH HHS R35 GM118171
6 · The paper itself

Abstract

Constitutively active G protein α subunits cause cancer, cholera, Sturge-Weber syndrome, and other disorders. Therapeutic intervention by targeted inhibition of constitutively active Gα subunits in these disorders has yet to be achieved. We found that constitutively active Gα

Indexed as

AnimalsApoptosisCell DifferentiationCell Line, TumorDepsipeptidesGTP-Binding Protein alpha SubunitsGuanosine DiphosphateGuanosine TriphosphateHEK293 CellsHumansMiceNeoplasmsSignal TransductionDepsipeptidesFR900359GTP-Binding Protein alpha SubunitsGuanosine DiphosphateGuanosine Triphosphate

Identifiers

PMID30181242
PMCPMC6279241
OpenAlexW2890746219

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.